Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...

Pfizer ( PFE) CEO Albert Bourla said Tuesday he has a "special relationship" with President Trump, cemented during the ...

Trump is changing Medicare, mostly focusing on providers. But the biggest impact may come from tariffs and deporting ...

Days after he sent letters instructing top pharmaceutical manufacturers to use a “most favored nation” pricing model for ...

But this year, the birthday of Medicaid and Medicare is more an occasion for worry than celebration. Recent changes signed ...

As investors and industry watchers juggle the twin possibilities of pharmaceutical import tariffs and potential drug pricing ...

The drugs reportedly under consideration for coverage include Novo Nordisk's Wegovy and Ozempic, and Eli Lilly's Zepbound and ...

Several companies, including Oracle and Microsoft, are expected to sign pledges to work on the Trump administration ...

Under his “Big Ugly Bill,” the richest Americans are projected to receive at least $12,000 in the form of tax cuts and other subsidies from the American people and their tax money. By comparison, it ...

Dr. Mehmet Oz, the Administrator of the Centers for Medicare and Medicaid Services, discussed the impending changes to the ...

GOP lawmakers in 10 states have refused for a decade to expand Medicaid under the Affordable Care Act. But when President Trump got another whack at Obamacare, these holdout states went unrewarded.